Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
6,768,178
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
2,377,092
-
Shares change
-
+555,057
-
Total reported value, excl. options
-
$33,959,945
-
Value change
-
+$7,877,859
-
Number of buys
-
15
-
Number of sells
-
-6
-
Price
-
$14.29
Significant Holders of DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) as of Q4 2020
28 filings reported holding DRIO - DarioHealth Corp. - Common Stock, par value $0.0001 per share as of Q4 2020.
DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,377,092 shares
of 6,768,178 outstanding shares and own 35.12% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (594,222 shares), Phoenix Holdings Ltd. (406,065 shares), Soleus Capital Management, L.P. (401,606 shares), FRIESS ASSOCIATES LLC (360,931 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (142,100 shares), VANGUARD GROUP INC (103,216 shares), MEITAV DASH INVESTMENTS LTD (86,850 shares), Psagot Investment House Ltd. (51,900 shares), GEODE CAPITAL MANAGEMENT, LLC (43,660 shares), and ROYAL BANK OF CANADA (39,312 shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.